Published in Lancet on June 05, 1971
Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins. J Clin Invest (1972) 1.58
Problem fracture in Paget's disease of bone. J R Soc Med (1989) 1.40
Glucagon in the treatment of Paget's disease of bone. Br Med J (1971) 1.28
An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest (1972) 1.16
Paget's disease in a 5-year-old: acute response to human calcitonin. Br Med J (1972) 0.98
Treatment of Paget's disease of bone with synthetic salmon calcitonin. Br Med J (1974) 0.88
Long-term treatment of Paget's disease of bone with salmon calcitonin. Can Med Assoc J (1977) 0.82
Evidence that calcitonin stimulates 1,25-dihydroxyvitamin D production and intestinal absorption of calcium in vivo. J Clin Invest (1986) 0.81
Treatment of Paget's disease of bone with once a week injections of salmon calcitonin. Br Med J (1975) 0.80
Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment. Br Med J (1977) 0.79
Crosslink in bone collagen in Paget's disease. J Clin Pathol (1975) 0.79
Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods. Can Med Assoc J (1977) 0.78
Effect of calcitonin treatment on osteoclast counts in Paget's disease of bone. J Clin Pathol (1978) 0.78
Clinical applications of calcitonin. Can Med Assoc J (1971) 0.75
Editorial: Paget's disease and calcitonin. Br Med J (1975) 0.75
Compression of cord by Paget's disease. Br Med J (1973) 0.75
Treating Paget's disease. Br Med J (Clin Res Ed) (1987) 0.75
Treatment with calcitonin. Br Med J (1973) 0.75
Medicine in old age. Disturbances of the special senses and other functions. Br Med J (1974) 0.75
Chronic treatment of Paget's disease of bone with synthetic human calcitonin. Yale J Biol Med (1982) 0.75
Medical staff conference. Paget disease of bone. West J Med (1978) 0.75
Endocrine bone disease. Proc R Soc Med (1973) 0.75
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
Selective fermentation: Alcoholic fermentation of glucose, fructose and mannose mixtures. Biochem J (1930) 5.75
Selective fermentation: Fermentation of sugar mixtures by Sauterne yeast. Biochem J (1930) 5.45
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
The Hagedorn-Jensen method applied to various sugars: Relation of reducing power to configuration. Biochem J (1930) 4.62
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract (2010) 2.75
Psychiatric morbidity and compulsory admission among UK-born Europeans, Afro-Caribbeans and Asians in central Manchester. Br J Psychiatry (1993) 2.52
The lipoids of spleen and liver in various types of lipoidosis. Biochem J (1933) 2.48
The problem of associating coagulase-negative staphylococci with disease. Ann N Y Acad Sci (1965) 2.43
Pituitary ablation for diabetic retinopathy. Q J Med (1965) 2.34
Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet (1974) 2.30
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology (1989) 2.24
The AKT kinase is activated in multiple myeloma tumor cells. Blood (2001) 2.20
Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science (1985) 2.10
Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med (1990) 2.09
American Academy of Pediatrics. Committee on Adolescence. Contraception in adolescents. Pediatrics (1999) 2.06
Is alignment within 8 prism diopters of orthotropia a successful outcome for infantile esotropia surgery? Arch Ophthalmol (1996) 2.06
Isolation and characterization of human calcitonin gene-related peptide. Nature (1984) 2.03
Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol (1998) 2.00
Should baseline PSA testing be performed in men aged 40 to detect those aged 50 or less who are at risk of aggressive prostate cancer? S Afr Med J (2011) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Diabetic retinopathy. I. The assessment of severity and progress by comparison with a set of standard fundus photographs. Diabetologia (1967) 1.93
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Assessment of health needs and willingness to utilize health care resources of adolescents in a suburban population. J Pediatr (1983) 1.90
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90
Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke (1996) 1.86
Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res (1991) 1.86
Single incision total extraperitoneal (one SITE) laparoscopic inguinal hernia repair using a single access port device. Hernia (2009) 1.83
Affinity of calciferol analogues for 25-hydroxycholecalciferol receptors. Clin Sci Mol Med (1974) 1.83
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Trial of Whooping-cough Vaccine. Br Med J (1945) 1.76
Epilepsy and employment. Community Health (Bristol) (1976) 1.75
Ampicillin levels in sputum, serum, and saliva. Thorax (1970) 1.73
Rocuronium: high risk for anaphylaxis? Br J Anaesth (2001) 1.72
Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect (2007) 1.72
Vitamin-D deficiency and primary hyperparathyroidism. Lancet (1971) 1.71
Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med (1991) 1.71
Blood volume replacement in acute anaphylactic cardiovascular collapse related to anaesthesia. Br J Anaesth (1977) 1.70
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS (1994) 1.70
Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol (1986) 1.68
Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol (1963) 1.67
Effect of thyrocalcitonin in man. Lancet (1966) 1.67
Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. Neurosci Lett (1985) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Calcium metabolism and bone pathology in adult coeliac disease. Q J Med (1970) 1.63
An assessment of radiological criteria used in the study of spinal osteoporosis. Br J Radiol (1967) 1.62
A pilot qualitative analysis of the psychosocial factors which drive young people to decline chlamydia testing in the UK: implications for health promotion and screening. Int J STD AIDS (2010) 1.60
Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke (2004) 1.59
The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK. Int J STD AIDS (2012) 1.59
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Immunohematologic characteristics of infection-associated cerebral infarction. Stroke (1991) 1.55
Retracted Altered calcitonin gene in a young patient with osteoporosis. BMJ (1989) 1.55
Phosphate treatment of hypercalcaemia due to carcinoma. Br Med J (1968) 1.54
A biological assay for calcitonin. J Endocrinol (1965) 1.53
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther (1981) 1.52
Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats : correlation with histopathology. Stroke (2000) 1.52
Atherosclerosis: current concepts on pathogenesis and interventional therapies. Ann Neurol (1989) 1.51
Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol (1978) 1.50
The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med (1982) 1.49
Nanometal surface energy transfer in optical rulers, breaking the FRET barrier. J Am Chem Soc (2005) 1.48
Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation. Diabetes (1976) 1.48
Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet (1981) 1.47
Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med (1976) 1.46
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med (2010) 1.45
Does bilateral internal thoracic artery grafting increase surgical risk in diabetic patients? Ann Thorac Surg (1998) 1.45
A physiological role for calcitonin: protection of the maternal skeleton. Lancet (1979) 1.44
Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect (2007) 1.44
A radioimmunoassay for human calcitonin M. Lancet (1969) 1.43
The calcitonin-like sequence of the beta CGRP gene. FEBS Lett (1986) 1.43
Hypermagnesemic pseudocoma. Arch Intern Med (1993) 1.42
Parathyroid hormone and experimental osteosclerosis. Lancet (1970) 1.42
Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr (2001) 1.41
Bicoronary-pulmonary fistulae with coexistent mitral valve prolapse: a case report and literature review of coronary-pulmonary fistula. Eur Heart J (1994) 1.39
Should syphilis be treated differently in HIV-positive and HIV-negative individuals? Treatment outcomes at a university hospital, Brighton, UK. Int J STD AIDS (2009) 1.39
Cushing's disease. Treatment by pituitary implantation of radioactive gold or yttrium seeds. Q J Med (1973) 1.39
Unexpected resistance in an African immigrant: lessons for the unwary. Sex Transm Infect (2004) 1.39
Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res (1984) 1.39
Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke (1996) 1.38
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. Int J STD AIDS (1996) 1.38
Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology (1992) 1.38
Eating disorders in adolescents. A position paper of the Society for Adolescent Medicine. J Adolesc Health (1995) 1.36
Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes. Diabetologia (2004) 1.36
Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes (1982) 1.36
Deafness in Paget's diseases: effect of salmon calcitonin treatment. Br Med J (1975) 1.35
Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J Clin Invest (1989) 1.35
Maternal factors and low birthweight infants: a comparison of blacks with Mexican-Americans. J Fam Pract (1987) 1.34
Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology (1998) 1.34
Chemistry, physiology, and therapeutic applications of calcitonin. Arthritis Rheum (1980) 1.34